Etiket: pharma
Largest IPO in 2023: This is how the SCHOTT Pharma share has developed since its IPO – and this could continue in 2024
On September 28, 2023, SCHOTT Pharma celebrated its successful stock market debut in Frankfurt. After being promoted to the SDAX, the preliminary figures for the past financial year were also…
Pharma Foods International presented results for the past quarter
Pharma Foods International presented its financial results for the most recent quarter on December 12, 2023. Earnings per share of JPY 9.94 were reported. In the same quarter last year,…
SCHOTT Pharma celebrates successful stock market debut: initial price above issue price
After the IPO of SCHOTT Pharma, the German stock exchange has gained a new billion-dollar company. • SCHOTT Pharma celebrates its stock market debut• Initial price above issue price• Valuation…
NVIDIA invests in pharmaceutical companies: Recoursion Pharma stock jumps almost 80 percent
Chip giant NVIDIA has boosted the share price of a medical company with a private investment in public equity (PIPE) transaction. • NVIDIA invests 50 million in Techbio company Recursion…
Pharma company cleared out! Police are looking for burglar duo
From the BZ editorial team With surveillance images and a video, the Berlin police are looking for two burglars who robbed the office of a pharmaceutical company in December last…
Medicine distributor Pharma Belgium-Belmedis fined 30 million euros for price agreements with competitor Febelco
The Belgian Competition Authority (BMA) is taking action against the drug distributors Febelco and Pharma Belgium-Belmedis because they have made price agreements with each other for years. For that reason,…
Controversial ‘Pharma Bro’ Martin Shkreli ordered to pay back $64 million and receive lifelong ban from pharmaceutical industry
Martin Shkreli, the former CEO of a pharmaceutical company that increased the price of a life-saving drug by about 4,000 percent overnight, has been ordered by a judge to refund…
Despite countless injections, pharma loses due to corona | Financial
Premium The best of De Telegraaf AstraZeneca and Johnson & Johnson drop out Amsterdam – Pfizer, BioNTech and Moderna, which earn very well from their corona vaccines, are generating quite…